JBS:NYSEJBS N.V. Analysis
Data as of 2026-09-05 - not real-time
$13.03
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
JBS N.V. is priced at $13.03, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have gained 6.1%. With RSI at 42.9 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $12.70 and resistance at $14.31.
Valuation screens as undervalued, on a P/E of 12.3 with no clean sector comparison available. Consensus targets land 40.6% above where the shares trade now. Revenue is growing at 13.8% on a 1.2% profit margin. The 10.22% dividend yield looks stretched against payout coverage.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 43.3%, a beta of 0.21 and a maximum drawdown of 36.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Valuation screens as undervalued, on a P/E of 12.3 with no clean sector comparison available. Consensus targets land 40.6% above where the shares trade now. Revenue is growing at 13.8% on a 1.2% profit margin. The 10.22% dividend yield looks stretched against payout coverage.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 43.3%, a beta of 0.21 and a maximum drawdown of 36.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Top Market Events
JBS N.V. NYSE:JBS shares edged lower in pre-market trading on Tuesday after the meat producer reported second-quarter...JBS NV JBS posts record Q2 net sales of $24 billion, with strategic partnerships and operational improvements...Subject to Approval of Independent and Disinterested Special Committee of PPC Board of Directors and Votes Cast by...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 14.50
- MACD momentum is negative
- 30-day price change of +6.1%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Dividend yield of 10.22% looks stretched against payout coverage
- Trading below the 200-day average of 14.50
- Analyst targets imply +40.6% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Dividend yield of 10.22% looks stretched against payout coverage
- Analyst targets imply +40.6% versus the current price
- Revenue growth of +13.8%
Key Metrics & Analysis
Financial Health
Revenue Growth13.80%
Profit Margin1.22%
P/E Ratio12.3
ROE13.38%
ROA4.92%
Debt/Equity283.04
P/B Ratio1.7
Op. Cash Flow$3.0B
Free Cash Flow$822.6M
Technical Analysis
TrendNeutral
RSI42.9
Support$12.70
Resistance$14.31
MA 20$13.51
MA 50$13.00
MA 200$14.50
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48
Valuation
Target Price$18.31
Upside/Downside40.56%
GradeUndervalued
TypeValue
Dividend Yield10.22%
Risk Assessment
Beta0.21
Volatility43.25%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.